- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06153745
Aspheric Monofocal Intraocular Lens in Pediatric Patients
July 19, 2024 updated by: Luca Buzzonetti
Aspheric Monofocal Intraocular Lens With Higher Order Aspheric Optic in Pediatric Patients: Early Outcomes
To evaluate the performance a new aspheric monofocal intraocular lens (IOL) with higher order aspheric optic for far, intermediate, and near vision, in pediatric patients after monolateral cataract surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
thirteen patients (mean age 7.6±3.8
years) who underwent cataract surgery and simultaneous implantation of the Tecnis Eyhance ICB00 IOL were evaluated.
Visual acuity was assessed three months after surgery for distance (CDVA), intermediate (CIVA) and near visual acuity (CNVA).
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Roma, Italy
- Luca Buzzonetti
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
primary care clinic
Description
Inclusion Criteria:
- monolateral cataract
Exclusion Criteria:
- other ocular diseases
- systemic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Corrected Intermediate Visual Acuity
Time Frame: 3 months postoperatively
|
Decimal
|
3 months postoperatively
|
|
Corrected Near Visual Acuity
Time Frame: 3 months postoperatively
|
Decimal
|
3 months postoperatively
|
|
Corrected Distance Visual Acuity
Time Frame: 3 months postoperatively
|
Decimal
|
3 months postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Luca Buzzonetti, Bambino Gesù Children's Hospital, Rome, Italy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
July 31, 2023
Study Completion (Actual)
July 31, 2023
Study Registration Dates
First Submitted
November 23, 2023
First Submitted That Met QC Criteria
November 23, 2023
First Posted (Actual)
December 1, 2023
Study Record Updates
Last Update Posted (Actual)
July 22, 2024
Last Update Submitted That Met QC Criteria
July 19, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BG123
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.